Press release
September 2, 2025
CalciMedica to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
CalciMedica, Inc. (CALC)
LA JOLLA, Calif. , Sept. 2, 2025 /PRNewswire/ -- CalciMedica Inc. (" CalciMedica " or the "Company") (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory and